MedTrace Logo

Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up

NCT01644409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2012-07-19

No results posted yet for this study

Summary

Long term open label study on safety and durability of the Urgent-SQ tibial implant device for refractory overactive bladder syndrome (OAB).

Conditions

  • Overactive Bladder
  • Urinary Frequency or Urgency Adverse Event
  • Urinary Incontinence, Urge

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Dick Janssen, MD · Radboud University Nijmegen Medical Centre Dept of Urology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644409 on ClinicalTrials.gov